Director of Karuna Therapeutics, Inc. (NASDAQ:KRTX), Ignelzi Troy A., sells 900 shares worth $119,268
According to Karuna Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jun 16 07:01 PM, company Director, Ignelzi Troy A. disclosed selling 900 shares at a cost of $132.52. At the time of this transaction (Jun 14), this trade was worth $119,268 in total. As of Jun 14, Ignelzi Troy A. now owns 13,000 shares in total worth about $1,614,470.0.
For the last few recent trades made by Karuna Therapeutics, Inc. (NASDAQ:KRTX) Director, Ignelzi Troy A., we have the following information:
- SEC Form 4 filing: Jun 16: Sold 2,600 shares at the rate of $129.31 per share. Total worth of this trade was $336,200. Total number of shares owned as of Jun 16 were 13,000
- SEC Form 4 filing: May 10: Sold 7,000 shares at the rate of $110.07 per share. Total worth of this trade was $770,490. Total number of shares owned as of May 10 were 13,000
- SEC Form 4 filing: May 12: Sold 200 shares at the rate of $120.00 per share. Total worth of this trade was $24,000. Total number of shares owned as of May 12 were 13,000
Posted by
George Daniels
on Thursday June 17 2021, 10:36 AM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
